Effect of alpha4beta2 nicotinic acetylcholine receptor agonists and antagonists on learning in female rats during different phases of ovary cycle
Fedotova IuO1, Frolova HO2
- Pavlov Institute of Physiology RAS, Snt Petersburg, Russia
- Donetsk Natioanal University, Donetsk, Ukraine
DOI: https://doi.org/10.15407/fz60.04.080
Abstract
The present work was devoted to the comparative analysis of
a4в2 nicotinic acetylcholine receptors (nAChRs) in learning/
memory processes during ovary cycle assessed in adult female
rats. RJR-2403 (1.0 mg/kg, i.p.), a4в2 nAChRs agonist and
mecamylamine (1.0 mg/kg, i.p.), a4в2 nAChRs antagonist
were injected chronically during 14 days. The processes of
learning/memory were assessed in different models of learning:
passive avoidance performance and Morris water maze.
Chronic RJR-2403 administration to female rats improved
the passive avoidance performance in proestrous and estrous
as compared to the control animals. Also, RJR-2403 restored
spatial learning during proestrous phases in Morris water maze,
and stimulated the dynamics of spatial learning during estrous
phases. On the contrary, chronic mecamylamine administration
impaired non-spatial, and especially, spatial learning in females
during key phases of ovary cycle. The results of the study suggest
positive effect of a4в2 nAChRs stimulation in learning/
memory processes during ovary cycle in the adult female rats.
Key words: RJR-2403, mecamylamine, a4в2 nAChRs, learning,
ovary cycle, female rats.
Keywords:
RJR-2403, mecamylamine, a4в2 nAChRs, learning,ovary cycle, female rats.
References
- Warren SG, Juraska JM. Spatial and nonspatial learning across the rat estrous cycle.Behav Neurosci. 1997; 2: 259-266.
CrossRef
- Jensen AA, Frolund B, Liljefors T, Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 2005; 48: 4705- 4745.
CrossRef
PubMed
- Hogg RC, Raggenbass M, Bertrand D. Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol. 2003; 147: 1-46.
CrossRef
PubMed
- Picciotto MR. Nicotine as a modulator of behavior: beyond the inverted. U Trends Pharmacol Sci. 2003; 24: 493-499.
CrossRef
- Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacol. 2006; 31: 2065-2078.
CrossRef
PubMed
- Norbury R, Travis MJ, Erlandsson K, Waddington W, Ell PJ Murphy DG. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPETstudy. Horm Behav. 2007; 51: 249-257.
CrossRef
PubMed
- Pompili A, Tomaz C, Arnone B, Tavares MC, Gasbarri A. Working and reference memory across the estrous cycle of rat: a long term study in gonadally intact females. Behav Brain Res. 2010; 213: 10-18.
CrossRef
PubMed
- Pompili A, Benedetto AA., Gasbarri A. Estrogens and memory in physiological and neuropathological conditions. Psychoneuroendocrinol. 2012; 37: 1379-1396.
CrossRef
PubMed
- Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006; 16: 710-715.
CrossRef
PubMed PubMedCentral
- Kirshenblat YaD. Workshop on Endocrinology. "Moscow;1969.
- Bures J, Buresova O, Huston J. Techniques and basic experiments
for the study of brain and behavior. Moscow. 1991.
- Ponomarev DB, Vinogradova EP. Comparative analysis of the learning ability in Morris water test in rats with the various rate of active acquisition of the avoidance conditioned reflex. IP Pavlov J Higher Nervous Activity. 2000; 50 (6): 974-981.
- Daniel JM, Fader, Spencer AJ, Dohanich AL. Estrogen enhances performance of female rats during acquisition of a radial arm maze. Horm Behav. 1997; 32: "Q.217-225.
- Warren SG, Juraska JM. Spatial and nonspatial learning across the rat estrous cycle. Behav Neurosci. 1997; 2: 259-266.
CrossRef
- Flores CM, Rogers SW, Pabreza LA., Wolfe BB, Kellar KJ. Asubtype of nicotinic cholinergic receptor in rat brain is composed of ?i4 and ?A2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol. 1992; 41: 31-37.
PubMed
|